Mobile Trading

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE5341.25-214.85 (-3.87 %)
PREV CLOSE ( ) 5556.10
OPEN PRICE ( ) 5450.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3466
TODAY'S LOW / HIGH ( )5305.00 5527.45
52 WK LOW / HIGH ( )3131.1 7208
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
3057.89
3110.72
2954.67
2847.03
Total Expenditure
2907.33
2583.12
2282.22
2248.55
PBIDT (Excl OI)
150.56
527.6
672.45
598.48
Other Income
96.6
83.73
81.04
79.97
Operating Profit
247.16
611.32
753.49
678.46
Interest
6.13
5
1.54
0.88
Exceptional Items
NA
164.26
NA
-402.29
PBDT
241.03
770.58
751.95
275.29
Depreciation
37.05
36.74
37.98
42.49
Profit Before Tax
203.98
733.84
713.97
232.8
Tax
45.98
210.15
175.37
60.09
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
158
523.69
538.6
172.71
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
158
523.69
538.6
172.71
Equity Capital
50
50
50
50
Face Value (IN RS)
2
2
2
2
Reserves
Calculated EPS
6.31
20.94
21.54
6.90
Calculated EPS (Annualised)
25.28
83.79
86.17
27.63
No of Public Share Holdings
6250000
6250000
6250000
6250000
% of Public Share Holdings
25
25
25
25
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
4.92
16.96
22.75
21.02
PBIDTM%
8.08
19.65
25.50
23.83
PBDTM%
7.88
24.77
25.44
9.66
PBTM%
6.67
23.59
24.16
8.17
PATM%
5.16
16.83
18.22
6.06
 
Notes
Notes
Notes
Notes
  • attention investors
  • kyc
  • ipo
  • ibt trading

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.